Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2025
FDA Approval Summary: Afamitresgene Autoleucel for Adults with HLA-Restricted, MAGE-A4-Positive Unresectable or Metastatic Synovial Sarcoma after Prior ChemotherapyKatherine K Barnett, Abigail R Johnson, Asha Das, et al.
Clinical Lung Cancer|August 25, 2011
A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancerAlexander I Spira, Nicholas O Iannotti, Michael A Savin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2025
FDA approval summary: Lifileucel for unresectable or metastatic melanoma previously treated with an anti-PD-1 based immunotherapyLianne Hu, Chaohong Fan, Peter Bross, et al.
The Oncologist|December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN studyJames J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology|November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumabMichael Prados, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology|May 12, 2011
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumabJeffrey S Wefel, Timothy Cloughesy, James L Zazzali, et al.
Neuro-Oncology|May 16, 2018
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FCTimothy F Cloughesy, Joseph Landolfi, Michael A Vogelbaum, et al.
Science Translational Medicine|June 3, 2016
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade gliomaTimothy F Cloughesy, Joseph Landolfi, Daniel J Hogan, et al.
Pageof 3